Protecting Your DNA: Legislation Against Data Exploitation
Submitted by MAGA
Posted 7 hours ago
**Alert: Your DNA Is At Risk in This New Age of Increased Surveillance**
The recent sale of the genetic data company 23andMe to Regeneron Pharmaceuticals has raised significant concerns about the protection of sensitive consumer information.
A coalition of lawmakers, primarily from the Republican side, has stepped up to address these concerns with the introduction of the "Don't Sell My DNA Act."
Senators John Cornyn and Chuck Grassley are leading this bipartisan effort, with support from Democratic Senator Amy Klobuchar.
The bill aims to update the bankruptcy code to ensure genetic information is classified as personally identifiable information (PII).
In the wake of 23andMe's bankruptcy and subsequent asset sale for $256 million, there are fears that genetic data could be mishandled, abused, or even exploited against consumers.
Current regulations are insufficient to protect this sensitive data, leaving it vulnerable in bankruptcy proceedings where companies might prioritize profits over consumer rights.
Revolutionizing the definition of PII to include genetic data would provide necessary safeguards against unauthorized sales or use of biometric information without explicit consumer consent.
Senator Cornyn emphasized the importance of this legislation, stating it will safeguard Americans' sensitive genetic information, preventing potential exploitation and ensuring transparency in its usage.
With the rise of Big Pharma's involvement in personal health data, such bills are crucial to ensuring that consumer rights are upheld, particularly in a landscape where medical privacy hangs in the balance.
Americans must remain vigilant about the implications of their genetic information being treated like a commodity, especially as data privacy continues to become more precarious.
This legislative measure represents a critical step toward securing the trust and safety of the American public in a world increasingly dictated by data-driven decisions.
As the threat of misuse from both corporate and governmental interests looms, it is essential for the American people to demand accountability and transparency in how their genetic data is managed.
In backing initiatives like the "Don't Sell My DNA Act," conservative leaders are taking a stand for consumer rights, ensuring that genetic information doesn't become a tool of surveillance and control, but rather remains a personal private matter.
As discussions continue, Americans should think carefully about where they share their sensitive information and advocate for stronger protections in this evolving digital age.
Sources:
zerohedge.com
revolver.news
infowars.com
The recent sale of the genetic data company 23andMe to Regeneron Pharmaceuticals has raised significant concerns about the protection of sensitive consumer information.
A coalition of lawmakers, primarily from the Republican side, has stepped up to address these concerns with the introduction of the "Don't Sell My DNA Act."
Senators John Cornyn and Chuck Grassley are leading this bipartisan effort, with support from Democratic Senator Amy Klobuchar.
The bill aims to update the bankruptcy code to ensure genetic information is classified as personally identifiable information (PII).
In the wake of 23andMe's bankruptcy and subsequent asset sale for $256 million, there are fears that genetic data could be mishandled, abused, or even exploited against consumers.
Current regulations are insufficient to protect this sensitive data, leaving it vulnerable in bankruptcy proceedings where companies might prioritize profits over consumer rights.
Revolutionizing the definition of PII to include genetic data would provide necessary safeguards against unauthorized sales or use of biometric information without explicit consumer consent.
Senator Cornyn emphasized the importance of this legislation, stating it will safeguard Americans' sensitive genetic information, preventing potential exploitation and ensuring transparency in its usage.
With the rise of Big Pharma's involvement in personal health data, such bills are crucial to ensuring that consumer rights are upheld, particularly in a landscape where medical privacy hangs in the balance.
Americans must remain vigilant about the implications of their genetic information being treated like a commodity, especially as data privacy continues to become more precarious.
This legislative measure represents a critical step toward securing the trust and safety of the American public in a world increasingly dictated by data-driven decisions.
As the threat of misuse from both corporate and governmental interests looms, it is essential for the American people to demand accountability and transparency in how their genetic data is managed.
In backing initiatives like the "Don't Sell My DNA Act," conservative leaders are taking a stand for consumer rights, ensuring that genetic information doesn't become a tool of surveillance and control, but rather remains a personal private matter.
As discussions continue, Americans should think carefully about where they share their sensitive information and advocate for stronger protections in this evolving digital age.
Sources:
zerohedge.com
revolver.news
infowars.com
Latest News